Starting with 5‐formyl‐6,7‐dimethyl‐5,6,7,8‐tetrahydropterine (II), a new synthesis of 5,6,7‐trimethyl‐5,6,7,8‐tetrahydropterine (III) is described. Thereby the chemical behaviour of the 5‐formyl group in II is investigated, in order to enable the unequivocal differentiation between formylation at position 5 and at position 10 in folic and tetrahydrofolic acid derivatives. 13C‐NMR. spectra of II and III are discussed.
No takes yet. Share an insight, caveat, or question.
Bieri et al. (1974) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: